News

IIT Delhi Has Just Opened Two New Innovation Facilities With ICICI Foundation — One for Advanced Manufacturing, One for Healthcare Biotech Startups

By Darshan S, Editor · 26 June, 2026 · 2 min read

Darshan S, Editor — IIT Delhi Has Just Opened Two New Innovation Facilities With ICICI Foundation — One for Advanced Manufacturing, One for Healthcare Biotech Startups

Summary

  • IIT Delhi Opens FSM Lab and BioNEST Bio Innovation Lab With ICICI Foundation for Healthcare and Manufacturing Startups
  • IIT Delhi and ICICI Foundation have inaugurated two new facilities — the Foundation for Smart Manufacturing Lab and the enhanced BioNEST Bio Innovation Lab for healthcare, diagnostics, and precision medicine translational research.

"These facilities bridge the gap between discovery and deployment. The FSM Lab gives startups and MSMEs the tools to test, validate, and commercialise Industry 4.0 technologies. The Bio Innovation Lab does the same for healthcare, diagnostics, and precision medicine — and both sit inside one of India's most active incubation ecosystems."

The Indian Institute of Technology Delhi, in collaboration with ICICI Foundation, has inaugurated two advanced facilities under the auspices of FITT — the Foundation for Innovation and Technology Transfer — IIT Delhi's institutional bridge between academic research and commercial product development. The two new facilities are the upgraded Foundation for Smart Manufacturing Lab, a platform for Industry 4.0 technology development and commercialisation for startups and MSMEs; and the enhanced Bio Innovation Lab under BioNEST, IIT Delhi's biotechnology incubator, providing state-of-the-art infrastructure for translational research across healthcare, diagnostics, precision medicine, genomics, and medical technologies.

The two facilities serve a shared institutional purpose: reducing the commercial infrastructure gap that prevents innovative research from reaching market. The FSM Lab, as the Foundation for Smart Manufacturing Lab is known, is equipped with advanced manufacturing systems, automation technologies, and rapid prototyping capabilities — allowing startups and MSMEs to develop, test, refine, and commercialise next-generation products without requiring the capital investment of building their own manufacturing and testing infrastructure. This access-to-infrastructure model is the same rationale behind Germany's Fraunhofer Institutes and the United States's Manufacturing Extension Partnership network — and it is an infrastructure layer that India's startup ecosystem has historically lacked.

The Bio Innovation Lab and BioNEST

The Bio Innovation Lab sits within BioNEST — IIT Delhi's Biotechnology Incubator, which itself operates under FITT's institutional umbrella. BioNEST has been one of India's more active healthcare startup incubation environments, supporting companies in diagnostics, medical devices, biotechnology, and precision medicine with laboratory access, mentorship, regulatory guidance, and investor connectivity.

The enhanced Bio Innovation Lab upgrades BioNEST's physical infrastructure for translational research and product development in healthcare, diagnostics, precision medicine, genomics, and medical technologies — the categories that define where India's healthcare innovation is moving. Access to genomic sequencing infrastructure, precision medicine research equipment, and diagnostic development tools at the IIT Delhi campus level significantly lowers the entry barrier for healthcare founders who need laboratory-grade infrastructure to validate their technologies before they can attract the investor attention needed to build their own facilities.

FITT as the Commercialisation Bridge

FITT — the Foundation for Innovation and Technology Transfer — occupies the institutional space between IIT Delhi's research ecosystem and the commercial market that research outputs ultimately need to reach. FITT manages intellectual property generated at IIT Delhi, facilitates technology licensing agreements with industry, runs the incubation programme that includes BioNEST, and provides the administrative and legal infrastructure that enables technology transfer. The ICICI Foundation's support for both the FSM Lab and the BioNEST Bio Innovation Lab reflects the philanthropic CSR model that is increasingly funding India's research translation infrastructure — similar to the Axis Bank-BITS Pilani ₹100 crore research park covered in BHC Media's June 18 edition.

The IIT Delhi Bharat Innovates Momentum

The new facility inaugurations occur in the wake of IIT Delhi's strong presence at Bharat Innovates 2026 in Nice, France (June 14-16) — where IIT Delhi served as co-chair of the Incubator Innovation Bridge alongside IIT Bombay, signed multiple international MoUs including with Sorbonne University and French deeptech companies, and showcased innovations from 120 selected startups across 13 frontier sectors. The Bharat Innovates momentum has accelerated IIT Delhi's institutional attention on commercialisation infrastructure — and the FSM Lab and Bio Innovation Lab are direct investments in that commercialisation agenda.

"BHC Perspective"

At Bengaluru Health Community, IIT Delhi's FSM Lab and BioNEST Bio Innovation Lab are precisely the kind of academic-industrial translation infrastructure that India's healthcare startup ecosystem needs but that Bengaluru-based founders often do not have visibility into. IIT Delhi, AIIMS Delhi, and the broader Delhi-NCR healthcare technology ecosystem are a complementary geography to Bengaluru's — and BHC's mentorship platform is specifically positioned to connect founders across both ecosystems. For BHC founders in diagnostics, precision medicine, medical device development, or biotech — BioNEST's enhanced infrastructure is now a resource worth engaging with directly.

Frequently Asked Questions

Q: What did IIT Delhi and ICICI Foundation inaugurate?
A: Two new facilities under FITT on June 23, 2026: the upgraded Foundation for Smart Manufacturing (FSM) Lab for Industry 4.0 technology development by startups and MSMEs, and the enhanced Bio Innovation Lab under BioNEST for translational research in healthcare, diagnostics, precision medicine, genomics, and medical technologies.

Q: What is BioNEST?
A: IIT Delhi's Biotechnology Incubator, managed through FITT, providing laboratory access, mentorship, regulatory guidance, and investor connectivity for healthcare startups in diagnostics, medical devices, biotechnology, and precision medicine. The enhanced Bio Innovation Lab significantly upgrades its physical translational research infrastructure.

Q: What role does FITT play?
A: FITT (Foundation for Innovation and Technology Transfer) bridges IIT Delhi's research ecosystem and commercial markets — managing IP, facilitating technology licensing, running incubation including BioNEST, and providing the institutional infrastructure for technology transfer from academic research to commercial product development.